ASCO: Nut Consumption Ups Survival in Stage III Colon Cancer

Share this content:
ASCO: Nut Consumption Ups Survival in Stage III Colon Cancer
ASCO: Nut Consumption Ups Survival in Stage III Colon Cancer

THURSDAY, May 18, 2017 (HealthDay News) -- Colon cancer patients might improve their odds of survival if they eat nuts along with consuming an overall healthy diet and getting regular exercise, according to two studies scheduled for presentation at the annual meeting of the American Society of Clinical Oncology, to be held from June 2 to 6 in Chicago.

The first study involved 826 patients with stage III colon cancer who had received surgery and chemotherapy. They all filled out diet questionnaires, including questions regarding their nut consumption. The patients were followed for about seven years after completing chemotherapy. Nearly 1 in 5 patients (19 percent) said they ate at least 2 ounces of nuts a week, and researchers found both a lower risk of cancer recurrence and higher overall survival in that group. Further analysis revealed that peanuts and peanut butter (from the legume family) did not provide any benefit.

The second study also focused on stage III colon cancer patients after chemotherapy. Researchers surveyed 992 patients about their lifestyles, scoring them against recommendations in the American Cancer Society's Nutrition and Physical Activity Guidelines for Cancer Survivors. Half were followed up to seven years, and half longer.

The researchers found that patients who adhered closely to the guidelines regarding exercise, diet, and excess weight had a 42 percent lower mortality risk than those who didn't. When drinking was included in the analysis, patients strictly following the American Cancer Society's lifestyle guidelines had a 51 percent lower mortality risk and a 36 percent lower risk of cancer recurrence.

Abstract 1
Abstract 2
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for ~25% ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »